Principal Investigator
Bradley Gampel
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240608
Clinical Trial Summary
A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
Phase
Phase I/II
Funding Agency/Sponsor
National Cooperative Group
Disease
Pediatric Cancer
Contact Information
Phone Number
305-243-2647